Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn(Martini-Klinik), Thorsten Schlomm(Charité - Universitätsmedizin Berlin)
Cited by 323
Related Papers
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
|Nature Biotechnology|2016|347
Table of Contents
|American Journal Of Pathology|2014|0